Industry

 The Be The Match Registry® includes more than 266,000 fully characterized CBUs, allowing for therapy-matched unit identification. MINNEAPOLIS–(BUSINESS WIRE)–Be The Match BioTherapies® announced it is now providing cryopreserved Cord Blood Units as allogeneic cell therapy starting material for non-clinical, clinical, and commercial use. The Be The Match Registry®, with more than 266,000 fully-characterized cord blood … [Read more…]

Mr. Claiborne Joined the CytRx Board of Directors as of the Annual Meeting LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, welcomes Mr. Cary J. Claiborne to the CytRx Board of Directors (the “Board”). Mr. Claiborne brings to CytRx a wealth … [Read more…]

Company awarded commercial GMP license following successful EMA inspection of Memphis CDMO facility MEMPHIS, Tenn.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories, International Inc. (NYSE: CRL) announced it has received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell therapy drug products for distribution in Europe, from the European Medicines Agency … [Read more…]

Largest annual global DNA forensics meeting convenes October 31 – November 3 in Washington D.C. MADISON, Wis.–(BUSINESS WIRE)–More than 1000 forensic DNA experts and law enforcement professionals from around the world will gather at the International Symposium on Human Identification (ISHI) October 31 – November 3 in Washington D.C. Keynote speaker DeNeen L. Brown, a … [Read more…]

ZYNLONTA® (loncastuximab tesirine-lpyl) net sales of $17.3 million in the second quarter of 2022 Ex-U.S. ZYNLONTA license agreement with Sobi® facilitates global patient access and extends cash runway into early 2025 Company to host conference call today at 8:30 a.m. EDT LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today reported financial results for the second … [Read more…]

Vaccines and Related Biological Products Advisory Committee will hold meeting on September 22, 2022 RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrent C. difficile infection after antibiotic treatment SAINT-PREX, Switzerland & PARSIPPANY, N.J.–(BUSINESS WIRE)–#FDA–Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the … [Read more…]

Agreement generates upfront payment and ongoing revenues, validating the European opportunity for medical cannabis LONDON–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower … [Read more…]

PORTOLA VALLEY, Calif.–(BUSINESS WIRE)–TransMed7, LLC announced today that the first clinical cases of the final commercial production version of the Sparrow device (a member of the new SpeedBird™ family of vacuum-assisted, Single Insertion / Multiple Collection (SIMC®) Breast Biopsy devices) were successfully performed by Dr. Edgar Staren, a distinguished surgeon and former President of the … [Read more…]

Late-breaking oral presentation at WCLC features first results from TROPION-Lung02 trial of Daiichi Sankyo and AstraZeneca’s TROP2 directed antibody drug conjugate TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Initial results from the TROPION-Lung02 phase 1b trial showed that datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy demonstrated promising clinical activity and a tolerable … [Read more…]

SEATTLE–(BUSINESS WIRE)–#spatialbiology–NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics using the GeoMx Human Whole Transcriptome Atlas (WTA) to construct a high-resolution molecular landscape of pancreatic cancer. This paper, along with a tissue image generated using the GeoMx® … [Read more…]